Is it worth screening elective orthopaedic patients for carriage of Staphylococcus aureus? : a part-retrospective case-control study in a Scottish hospital

Dancer, Stephanie J and Christison, Fraser and Eslami, Attaolah and Gregori, Alberto and Miller, Roslyn and Perisamy, Kumar and Robertson, Chris and Graves, Nick (2016) Is it worth screening elective orthopaedic patients for carriage of Staphylococcus aureus? : a part-retrospective case-control study in a Scottish hospital. BMJ Open, 6 (9). pp. 1-7. e011642. ISSN 2044-6055

[img]
Preview
Text (Dancer-etal-BMJ-2016-screening-elective-orthopaedic-patients-for-carriage-of-staphylococcus-aureus)
Dancer_etal_BMJ_2016_screening_elective_orthopaedic_patients_for_carriage_of_staphylococcus_aureus.pdf
Final Published Version
License: Creative Commons Attribution-NonCommercial 4.0 logo

Download (722kB)| Preview

    Abstract

    BACKGROUND: With recent focus on methicillin-resistant Staphylococcus aureus (MRSA) screening, methicillin-susceptible S. aureus (MSSA) has been overlooked. MSSA infections are costly and debilitating in orthopaedic surgery. METHODS: We broadened MRSA screening to include MSSA for elective orthopaedic patients. Preoperative decolonisation was offered if appropriate. Elective and trauma patients were audited for staphylococcal infection during 2 6-month periods (A: January to June 2013 MRSA screening; B: January to June 2014 MRSA and MSSA screening). Trauma patients are not screened presurgery and provided a control. MSSA screening costs of a modelled cohort of 500 elective patients were offset by changes in number and costs of MSSA infections to demonstrate the change in total health service costs. FINDINGS: Trauma patients showed similar infection rates during both periods (p=1). In period A, 4 (1.72%) and 15 (6.47%) of 232 elective patients suffered superficial and deep MSSA infections, respectively, with 6 superficial (2%) and 1 deep (0.3%) infection among 307 elective patients during period B. For any MSSA infection, risk ratios were 0.95 (95% CI 0.41 to 2.23) for trauma and 0.28 (95% CI 0.12 to 0.65) for elective patients (period B vs period A). For deep MSSA infections, risk ratios were 0.58 (95% CI 0.20 to 1.67) for trauma and 0.05 (95% CI 0.01 to 0.36) for elective patients (p=0.011). There were 29.12 fewer deep infections in the modelled cohort of 500 patients, with a cost reduction of £831 678 for 500 patients screened. CONCLUSIONS: MSSA screening for elective orthopaedic patients may reduce the risk of deep postoperative MSSA infection with associated cost-benefits.